Transient altered mental status and leptomeningeal enhancement associated with pembrolizumab: a case report

Neurol Sci. 2021 Nov;42(11):4771-4773. doi: 10.1007/s10072-021-05479-6. Epub 2021 Jul 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Humans
  • Magnetic Resonance Imaging*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab